Amro A. Albanna, CHIEF EXECUTIVE OFFICER at Aditx Therapeutics, Inc. (ADTX), bought 2,400 shares at $2.93 ($7K) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market purchase of $7k ADTX by CHIEF EXECUTIVE OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.89 | 100 | $289 | 4.1% |
| 2 | $2.90 | 800 | $2K | 33.0% |
| 3 | $2.93 | 500 | $1K | 20.9% |
| 4 | $2.95 | 1,000 | $3K | 42.0% |
| Total | $2.93 avg | 2,400 | $7K | 100% |